CAS: 1191911-27-9 - N-[2-[[5-Chloro-2-[[2-methoxy-4-(4-morpholinyl)phenyl]amino]-4-pyrimidinyl]amino]phenyl]methanesulfonamide
Formula:C22H25ClN6O4S
InChI:InChI=1S/C22H25ClN6O4S/c1-32-20-13-15(29-9-11-33-12-10-29)7-8-19(20)26-22-24-14-16(23)21(27-22)25-17-5-3-4-6-18(17)28-34(2,30)31/h3-8,13-14,28H,9-12H2,1-2H3,(H2,24,25,26,27)
InChI key:InChIKey=CLGWUCNXOBLWFM-UHFFFAOYSA-N
SMILES:O=S(=O)(NC=1C=CC=CC1NC2=NC(=NC=C2Cl)NC3=CC=C(C=C3OC)N4CCOCC4)C
- Synonyms:
- CZC 54252
- Methanesulfonamide, N-[2-[[5-chloro-2-[[2-methoxy-4-(4-morpholinyl)phenyl]amino]-4-pyrimidinyl]amino]phenyl]-
- N-[2-[[5-Chloro-2-[[2-methoxy-4-(4-morpholinyl)phenyl]amino]-4-pyrimidinyl]amino]phenyl]methanesulfonamide
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
CZC-54252 REF: IN-DA008TLNCAS: 1191911-27-9 | 98% | 35.00 €~568.00 € | Thu 02 Jan 25 | |
CZC-54252 REF: TM-T2022CAS: 1191911-27-9 | 99.39% | 38.00 €~323.00 € | Tue 07 Jan 25 | |
CZC-54252 REF: 3D-RXB91127CAS: 1191911-27-9 | Min. 95% | To inquire | Tue 11 Feb 25 |
CZC-54252
CAS:1191911-27-9
Formula:
C22H25ClN6O4S
Purity:
98%
Color and Shape:
Solid
Molecular weight:
504.9897
Ref: IN-DA008TLN
1mg | 35.00 € | ||
5mg | 64.00 € | ||
10mg | 83.00 € | ||
25mg | 130.00 € | ||
50mg | 160.00 € | ||
100mg | 252.00 € | ||
250mg | 568.00 € |
Estimated delivery in United States, on Thursday 2 Jan 2025
CZC-54252
CAS:1191911-27-9
CZC-54252 is a potent inhibitor of LRRK2.
Formula:
C22H25ClN6O4S
Purity:
99.39%
Color and Shape:
Solid
Molecular weight:
504.99
Ref: TM-T2022
1mg | 38.00 € | ||
2mg | 49.00 € | ||
5mg | 80.00 € | ||
10mg | 116.00 € | ||
25mg | 215.00 € | ||
50mg | 323.00 € | ||
1mL*10mM (DMSO) | 89.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
CZC-54252
CAS:1191911-27-9
CZC-54252 is a cellular therapeutic that stimulates the pluripotent stem cells to differentiate into muscle …
Formula:
C22H25ClN6O4S
Purity:
Min. 95%
Molecular weight:
504.99 g/mol
Ref: 3D-RXB91127
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 11 Feb 2025